Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Atherosclerotic plaque regression - the role of statin therapy.

Sastry P, Kaski JC.

Drugs Today (Barc). 2010 Aug;46(8):601-8. doi: 10.1358/dot.2010.46.8.1516983. Review.

PMID:
20830320
2.

Atherosclerotic plaque regression: fact or fiction?

Shanmugam N, Román-Rego A, Ong P, Kaski JC.

Cardiovasc Drugs Ther. 2010 Aug;24(4):311-7. doi: 10.1007/s10557-010-6241-0. Review.

PMID:
20549322
3.

Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?

Singh M, Bedi US.

Curr Atheroscler Rep. 2013 Jan;15(1):294. doi: 10.1007/s11883-012-0294-4. Review.

PMID:
23250630
4.

Development of Human-Like Advanced Coronary Plaques in Low-Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques.

Li Y, Fuchimoto D, Sudo M, Haruta H, Lin QF, Takayama T, Morita S, Nochi T, Suzuki S, Sembon S, Nakai M, Kojima M, Iwamoto M, Hashimoto M, Yoda S, Kunimoto S, Hiro T, Matsumoto T, Mitsumata M, Sugitani M, Saito S, Hirayama A, Onishi A.

J Am Heart Assoc. 2016 Apr 18;5(4):e002779. doi: 10.1161/JAHA.115.002779.

5.

Statin effects on atherosclerotic plaques: regression or healing?

Bittencourt MS, Cerci RJ.

BMC Med. 2015 Oct 8;13:260. doi: 10.1186/s12916-015-0499-9.

6.

Effect of statin therapy on the progression of coronary atherosclerosis.

Tian J, Gu X, Sun Y, Ban X, Xiao Y, Hu S, Yu B.

BMC Cardiovasc Disord. 2012 Sep 1;12:70. doi: 10.1186/1471-2261-12-70. Review.

7.

Statins improve human coronary atherosclerotic plaque morphology.

Reilly SD, Litovsky SH, Steinkampf MP, Caulfield JB.

Tex Heart Inst J. 2008;35(2):99-103.

8.

Statin treatment and progression of atherosclerotic plaque burden.

Grobbee DE, Bots ML.

Drugs. 2003;63(9):893-911. Review.

PMID:
12678574
9.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
10.

Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?

Akdim F, van Leuven SI, Kastelein JJ, Stroes ES.

Curr Pharm Des. 2007;13(10):1003-12. Review.

PMID:
17430164
11.

Statins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry.

Nakazato R, Gransar H, Berman DS, Cheng VY, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cury RC, Chinnaiyan K, Chow BJ, Delago A, Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines TC, Dunning A, Feuchtner G, Kim YJ, Leipsic J, Min JK.

Atherosclerosis. 2012 Nov;225(1):148-53. doi: 10.1016/j.atherosclerosis.2012.08.002. Epub 2012 Aug 24.

12.

Carotid atherosclerotic plaque stenosis: the stabilizing role of statins.

Artom N, Montecucco F, Dallegri F, Pende A.

Eur J Clin Invest. 2014 Nov;44(11):1122-34. doi: 10.1111/eci.12340. Epub 2014 Oct 4. Review.

PMID:
25231921
13.

Plaque stabilization: Can we turn theory into evidence?

Libby P, Sasiela W.

Am J Cardiol. 2006 Dec 4;98(11A):26P-33P. Epub 2006 Oct 2. Review.

PMID:
17126677
14.

A systematic review of the time course of atherosclerotic plaque regression.

Noyes AM, Thompson PD.

Atherosclerosis. 2014 May;234(1):75-84. doi: 10.1016/j.atherosclerosis.2014.02.007. Epub 2014 Feb 22. Review.

PMID:
24632041
15.

Plaque regression and improved clinical outcomes following statin treatment in atherosclerosis.

Girotra S, Murarka S, Migrino RQ.

Panminerva Med. 2012 Jun;54(2):71-81. Review.

PMID:
22525562
16.

Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Sato A, Nozato T, Miyake S, Takeyama Y, Morino Y, Yamauchi T, Muramatsu T, Hibi K, Terashima M, Michishita I; TRUTH Investigators.

Am J Cardiol. 2012 May 1;109(9):1247-53. doi: 10.1016/j.amjcard.2011.12.016. Epub 2012 Feb 9.

PMID:
22325089
17.

An emerging paradigm in atherosclerosis: focus on subclinical disease.

Miller M.

Postgrad Med. 2009 Mar;121(2):49-59. doi: 10.3810/pgm.2009.03.1976. Review.

PMID:
19332962
18.

Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.

Hartmann M, Huisman J, Böse D, Jensen LO, Schoenhagen P, Mintz GS, Erbel R, von Birgelen C.

Eur J Echocardiogr. 2011 Apr;12(4):313-21. doi: 10.1093/ejechocard/jer017. Epub 2011 Mar 18. Review.

PMID:
21421584
19.
20.

Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.

Ylä-Herttuala S, Bentzon JF, Daemen M, Falk E, Garcia-Garcia HM, Herrmann J, Hoefer I, Jukema JW, Krams R, Kwak BR, Marx N, Naruszewicz M, Newby A, Pasterkamp G, Serruys PW, Waltenberger J, Weber C, Tokgözoglu L.

Thromb Haemost. 2011 Jul;106(1):1-19. doi: 10.1160/TH10-12-0784. Epub 2011 Jun 14. Review.

PMID:
21670845

Supplemental Content

Support Center